Loading company…
Riskpilot
← Back to search
Sign in
Get full access
neu biologica ApS
APS
Dissolved
CVR 42378666
Trongårdsparken 103
Konsulentbistand vedrørende informationsteknologi · NACE 620200
Est. 2021
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2023
DKK 109K
-417% vs 2022
EBITDA margin
100.0%
+417% vs 2022
Equity ratio
60.7%
Financial strength
Net profit 2023
DKK 85K
+417% vs 2022
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
Key figures
Annual report 2023
Revenue
DKK 109K
-417%
EBITDA
DKK 109K
+417%
Net profit
DKK 85K
+417%
Total assets
DKK 162K
+353%
Equity
DKK 98K
+645%
Employees
—
—
Company information
Legal name
neu biologica ApS
CVR number
42378666
Legal form
Anpartsselskab
NACE code
620200 · Konsulentbistand vedrørende informationsteknologi
Founded
8. maj 2021
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen
Contact
Address
Trongårdsparken 103
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Konsulentbistand vedrørende informationsteknologi
Companies in Lyngby-Taarbæk
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
Income statement
DKK thousands
Item
2022
2023
Revenue
-34
109
Staff expenses
-0
-0
EBITDA
-34
109
Depreciation & amort.
-0
-0
EBIT
-34
109
Net financials
0
0
Profit before tax
-34
109
Tax
-8
24
Net profit
-27
85
Balance sheet
DKK thousands
Item
2022
2023
Total assets
36
162
Equity
13
98
Long-term debt
0
0
Short-term debt
23
64
Total debt
23
64
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2022
2023
Equity ratio
60.7%
This company
38.2%
Market median
+59% vs market
2022
2023
Return on equity
86.6%
This company
18.4%
Market median
+371% vs market
2022
2023
Net profit margin
78.0%
This company
8.1%
Market median
+863% vs market
2022
2023
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
2022
2023
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
2022
2023
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-05-08 – 2022-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
SK
Svend Kaj Petersen
Management
Management
2021 – 2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
FerrerasPetersen Holding ApS
Company
100%
100%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of neu biologica ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Svend Kaj Petersen
Management
0 companies